|
|
Volumn 1, Issue 2, 2006, Pages 146-148
|
|
Prehypertension and the cardiometabolic syndrome: is there any value in pharmacologic intervention?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ARTICLE;
BLOOD PRESSURE;
CARDIOVASCULAR DISEASE;
CASE REPORT;
DISEASE COURSE;
DRUG EFFECT;
HUMAN;
HYPERTENSION;
MALE;
METABOLIC SYNDROME X;
MIDDLE AGED;
PATHOPHYSIOLOGY;
PRACTICE GUIDELINE;
RISK ASSESSMENT;
RISK FACTOR;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
CARDIOVASCULAR DISEASES;
DISEASE PROGRESSION;
HUMANS;
HYPERTENSION;
MALE;
METABOLIC SYNDROME X;
MIDDLE AGED;
PRACTICE GUIDELINES;
RISK ASSESSMENT;
RISK FACTORS;
|
|
EID: 34548081201
PISSN: 15594564
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1559-4564.2006.05527.x Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
